FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure - Top-Institutions - MDSpire

FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure

  • By

  • Anaïs Corma-Gómez

  • Diana Corona-Mata

  • Jésica Martín-Carmona

  • María José Galindo

  • Angela Camacho

  • Carmen Martín-Sierra

  • Marina Gallo-Marín

  • Pilar Rincón

  • Ignacio Perez-Valero

  • Margarita Pérez-García

  • Angela Carrasco-Dorado

  • Juan A Pineda

  • Antonio Rivero-Juárez

  • Antonio Rivero

  • Luis M Real

  • Juan Macías

  • on behalf of the GEHEP-011 Study Group

  • April 8, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Infectious Diseases
    • Gastroenterology

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Hepatology
    • Virology
    • Gastroenterology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Infectious Diseases
    • Gastroenterology

  • #4

    Hospital Clinic Barcelona
    Hospital Clinic Barcelona

    Barcelona, Catalonia

    Key Differentiators

    • Hepatology
    • Infectious Diseases

  • #5

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - NIH
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - NIH

    Bethesda, MD

    Key Differentiators

    • Hepatology Research
    • Clinical Trials

Original Source(s)

FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure

  • by Anaïs Corma-Gómez, Diana Corona-Mata, Jésica Martín-Carmona, María José Galindo, Angela Camacho, Carmen Martín-Sierra, Marina Gallo-Marín, Pilar Rincón, Ignacio Perez-Valero, Margarita Pérez-García, Angela Carrasco-Dorado, Juan A Pineda, Antonio Rivero-Juárez, Antonio Rivero, Luis M Real, Juan Macías, on behalf of the GEHEP-011 Study Group

  • April 8, 2025

Related Content

Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program

Correlation of ABO/Rh Blood Types with Transfusion-Related Infections in Turkish Blood Donors: An In-Depth Demographic Study (2015–2021)